Medicine ❯Vaccines ❯Respiratory Syncytial Virus

Pfizer Abrysvo

Adults Children Distribution Market Value FDA Approval Efficacy CDC Recommendations Cost-effectiveness Guillain-Barré Syndrome Co-administration with Other Vaccines

FDA Approves Pfizer's RSV Vaccine for Seniors After Success in Late-Stage Trials